Pyelonephritis caused by Massilia timonae in a diabetic patient: a rare cause of urinary tract infection: a case report
Asmae Kidoun, Abderrazak Saddari, Imane Douichi, Said Ezrari, Mohammed Lahmer, Elmostapha Benaissa, Yassine Ben Lahlou, Mostafa Elouennass, Adil Maleb
Corresponding author: Asmae Kidoun, Laboratory of Microbiology, Faculty of Medicine and Pharmacy, University Mohammed First, Oujda, Morocco 
Received: 11 Jul 2026 - Accepted: 04 Sep 2026 - Published: 14 Sep 2026
Domain: Laboratory medicine
Keywords: Massilia timonae, pyelonephritis, urinary tract infection, MALDI-TOF, case report
Funding: This work received no specific grant from any funding agency in the public, commercial, or non-profit sectors.
©Asmae Kidoun et al. PAMJ Clinical Medicine (ISSN: 2707-2797). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cite this article: Asmae Kidoun et al. Pyelonephritis caused by Massilia timonae in a diabetic patient: a rare cause of urinary tract infection: a case report. PAMJ Clinical Medicine. 2026;22:3. [doi: 10.11604/pamj-cm.2026.22.3.54447]
Available online at: https://www.clinical-medicine.panafrican-med-journal.com//content/article/22/3/full
Case report 
Pyelonephritis caused by Massilia timonae in a diabetic patient: a rare cause of urinary tract infection: a case report
Pyelonephritis caused by Massilia timonae in a diabetic patient: a rare cause of urinary tract infection: case report
Asmae Kidoun1,2,
Abderrazak Saddari1,2,3, Imane Douichi1,2,
Said Ezrari1,3, Mohammed Lahmer1,2,3, Elmostapha Benaissa4,5, Yassine Ben Lahlou4,5, Mostafa Elouennass4,5,
Adil Maleb1,2,3
&Corresponding author
Massilia timonae is a rare non-fermenting Gram-negative bacillus of the family Oxalobacteraceae, first isolated in 1998. Fewer than fifteen human infections have been reported. We report the first case of acute pyelonephritis caused by M. timonae in an elderly diabetic woman with acute kidney injury. Pelvic urine culture yielded mucoid, oxidase-positive colonies identified by MALDI-TOF mass spectrometry. Antimicrobial susceptibility testing demonstrated sensitivity to carbapenems, fluoroquinolones, and aminoglycosides. Despite appropriate management, the outcome was fatal. This case expands the clinical spectrum of M. timonae and underscores the diagnostic value of MALDI-TOF in identifying unusual non-fermenting Gram-negative bacilli.
Urinary tract infections (UTIs) are among the most common bacterial infections. Although most are caused by Enterobacteriaceae, consider rare pathogens in elderly or immunocompromised patients. Massilia timonae, a non-fermenting aerobic Gram-negative bacillus, was first described in 1998 [1]. Fewer than fifteen human cases have been reported, with no previously documented urinary tract involvement. We report the first case of acute pyelonephritis due to M. timonae, identified by MALDI-TOF mass spectrometry.
Patient information: an elderly woman in her eighties with type 2 diabetes mellitus, hypertension, and a history of ischemic stroke with residual hemiplegia was admitted for acute kidney injury (AKI). All patient data were fully anonymized. The patient died during hospitalization; no next of kin could be reached for informed consent.
Clinical findings: on admission: creatinine 74 mg/L, urea 2.2 g/L, C-reactive protein 53 mg/L, white blood cell count 8,240/mm3 with neutrophilia (5,040/mm3). Cytobacteriological urine examination (CBEU) revealed turbid yellow urine with marked leukocyturia (1,600,000/mL) and fine granular casts on microscopy, consistent with upper urinary tract infection.
Timeline: day 1: admission for AKI with inflammatory syndrome (CRP 53 mg/L, leukocyturia). Day 2–3: urine culture yielding mucoid oxidase-positive Gram-negative bacilli. Day 3: MALDI-TOF identification of Massilia timonae; antibiogram performed. Day 4: transfer to intensive care unit. Day 5–7: fatal outcome despite appropriate management.
Diagnostic assessment: culture on cystine-lactose-electrolyte-deficient agar (CLED) and blood agar (48h, 37°C, aerobic) yielded mucoid, opaque, glistening colonies with a positive oxidase reaction, atypical for common uropathogens. Gram staining showed Gram-negative bacilli. MALDI-TOF mass spectrometry (Bruker Biotyper) confirmed identification with a high-confidence score for Massilia timonae. The main diagnostic challenge was the unusual morphology of the colonies, which could have led to misclassification as a contaminant by conventional methods alone (Figure 1).
Therapeutic interventions and follow-up: antimicrobial susceptibility testing (disk diffusion, EUCAST criteria) showed sensitivity to meropenem, ciprofloxacin, levofloxacin, amikacin, and tobramycin, with dose-dependent sensitivity to imipenem, cefepime, ceftazidime, and piperacillin-tazobactam. Appropriate antibiotic therapy was initiated. The patient was transferred to the intensive care unit; despite supportive management, the outcome was fatal. The fatal outcome reflects the severity of underlying comorbidities rather than intrinsic pathogen virulence, given the broad antibiotic sensitivity profile demonstrated.
Patient perspective: the patient died during hospitalization before any formal assessment of her perspective could be obtained. No next of kin could be reached. Therefore, patient perspective is not applicable in this case report.
Informed consent: this case report was conducted in accordance with the Declaration of Helsinki. The patient died during hospitalization, and no next of kin could be reached for informed consent. All patient data have been fully anonymized. The case is reported solely for its scientific and educational value. Written informed consent was waived due to the patient's death and the absence of reachable next of kin.
To our knowledge, this is the first documented case of urinary tract infection caused by M. timonae. Since its initial description [1], twelve cases have been published: septicemia [1,3,4], bone infections [2,3], central nervous system (CNS) involvement [3], corneal abscess [5], wound infection [6], septic abortion [7], and embryo culture contamination [8] (Table 1). Our case adds acute pyelonephritis to this spectrum. Massilia species are distributed in environmental reservoirs including soil, drinking water, and ambient air [9,10], suggesting a possible environmental route. Our patient had advanced age and diabetes mellitus as recognized risk factors for opportunistic infections. MALDI-TOF mass spectrometry was decisive for identification — conventional biochemical methods would likely have classified this isolate as an unidentified non-fermenting bacillus, potentially leading to misclassification or delayed diagnosis.
This case documents the first urinary tract infection caused by Massilia timonae, expanding its clinical spectrum. Clinicians and microbiologists should consider non-fermenting Gram-negative bacilli in atypical UTIs in elderly diabetic patients. MALDI-TOF mass spectrometry is indispensable for accurate identification of such rare organisms.
The authors declare no competing interests.
Asmae Kidoun: case identification, microbiological analysis, manuscript drafting. Abderrazak Saddari, Imane Douichi, Said Ezrari, Mohammed Lahmer: data collection, manuscript revision. Elmostapha Benaissa, Yassine Ben Lahlou, Mostafa Elouennass: critical revision. Adil Maleb: supervision and final approval. All authors read and approved the final manuscript.
The authors thank the laboratory staff of Mohammed VI University Hospital, Oujda, for their support.
Table 1: published human infections due to Massilia timonae
Figure 1: cultural characteristics of Massilia timonae on CLED agar after 48 hours of aerobic incubation at 37°C. Mucoid, opaque, circular, and glistening colonies are visible, morphologically atypical for common uropathogens
- La Scola B, Birtles RJ, Mallet MN, Raoult D. Massilia timonae gen nov, sp nov., isolated from blood of an immunocompromised patient with cerebellar lesions. J Clin Microbiol. 1998 Oct;36(10):2847-52. PubMed | Google Scholar
- Sintchenko V, Jelfs P, Sharma A, Hicks L, Gilbert GL. Massilia timonae: an unusual bacterium causing wound infection following surgery. Clin Microbiol Newsl. 2000 Oct1;22(19):149-51. Google Scholar
- Lindquist D, Murrill D, Burran WP, Winans G, Janda JM, Probert W. Characteristics of Massilia timonae and Massilia timonae-like isolates from human patients. J Clin Microbiol. 2003 Jan;41(1):192-6. PubMed | Google Scholar
- Van Craenenbroeck AH, Camps K, Zachée P, Wu KL. Massilia timonae infection presenting as generalized lymphadenopathy. J Clin Microbiol. 2011 Jul;49(7):2763-5. PubMed | Google Scholar
- Ballestero-Téllez M, Laborda Guirao T, Batista Diaz N, Pascual Hernandez Á. First reported case of a corneal abscess caused by Massilia timonae. Enferm Infecc Microbiol Clin. 2016;34(3):212-3. PubMed | Google Scholar
- Huang Y, Chao C, Tang H, Lin W. Massilia timonae wound infection. Ulutas Med J. 2018;4(3):172-4. Google Scholar
- Ali GA, Ibrahim EB, Doiphode SH, Goravey W. Massilia timonae bacteremia: an unusual causative agent of septic abortion. IDCases. 2022 Aug 2;29:e01592. PubMed | Google Scholar
- Shurygina AS, Guseva OS, Shurygina OV, Lyamin AV. A case of Massilia timonae identified during time-lapse ART cycles in a pre-implantation embryo. JBRA Assist Reprod. 2024;28(4):805-7. PubMed | Google Scholar
- Gallego V, Sanchez-Porro C, Garcia MT, Ventosa A. Massilia aurea sp nov, isolated from drinking water. Int J Syst Evol Microbiol. 2006 Oct;56(Pt 10):2449-2453. PubMed | Google Scholar
- Weon HY, Kim BY, Hong SB, Jeon YA, Koo BS, Kwon SW et al. Massilia niabensis sp. nov. and Massilia niastensis sp. nov., isolated from air samples. Int J Syst Evol Microbiol. 2009 Jul;59(Pt 7):1656-60. PubMed | Google Scholar





